NCT03092050 is a NA clinical trial of Guided Imagery and Mindfulness in Depression, sponsored by Massachusetts General Hospital.

Who is sponsoring NCT03092050?

NCT03092050 is sponsored by Massachusetts General Hospital.

What drugs are being tested in NCT03092050?

Interventions in NCT03092050: Guided Imagery and Mindfulness, Facilitated Discussion.

What condition does NCT03092050 study?

NCT03092050 studies Depression.

Is NCT03092050 still recruiting?

NCT03092050 is currently completed. Last updated 6 September 2022.

Last reviewed 2022-09-06 · How we verify

NCT03092050

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Group Therapy for Depressed Dementia Caregivers

Completed NA Last updated 6 September 2022

What this trial tests

NA trial testing Guided Imagery and Mindfulness in Depression in 46 participants. Completed in 30 June 2019.

Timeline

1 March 2017

Primary endpoint
30 June 2019

30 June 2019

Quick facts

Lead sponsor	Massachusetts General Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	46
Start date	1 March 2017
Primary completion	30 June 2019
Estimated completion	30 June 2019
Sites	1 location across United States

Drugs / interventions tested

Guided Imagery and Mindfulness
Facilitated Discussion

Conditions studied

Depression — all drugs for Depression →

Sponsor

Massachusetts General Hospital

Who can join

45 and older, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Depression in family caregivers of relatives with Alzheimer's Disorder and related dementias is a serious public health problem. This is a randomized, controlled, single-blind pilot clinical trial of depressed caregivers, to determine the efficacy and mechanisms of group therapy for depressed dementia caregivers.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Mindfulness-based stress reduction for family carers of people with dementia.
Liu Z, Sun YY, Zhong BL. · · 2018 · cited 27× · PMID 30106471 · DOI 10.1002/14651858.cd012791.pub2
Four-Week Mentalizing Imagery Therapy for Family Dementia Caregivers: A Randomized Controlled Trial with Neural Circuit Changes.
Jain FA, Chernyak SV, Nickerson LD, Morgan S, et al · · 2022 · cited 20× · PMID 35287133 · DOI 10.1159/000521950
Family dementia caregivers with suicidal ideation improve with mentalizing imagery therapy: Results from a pilot study.
Madarasmi S, Gutierrez-Ramirez P, Barsoum N, Banerjee S, et al · · 2024 · cited 6× · PMID 38737194 · DOI 10.1016/j.jadr.2024.100721

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Massachusetts General Hospital trials

Trials by the same sponsor.

NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis · withdrawn
NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg · NA · not yet recruiting
NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior · NA · not yet recruiting
NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries · NA · not yet recruiting
NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03092050 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
Last refreshed: 6 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03092050.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing